Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael F Moran

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|November 11, 2009
Multiple myeloma phosphotyrosine proteomic profile associated with FGFR3 expression, ligand activation, and drug inhibitionJonathan R St-Germain, Paul Taylor, Jiefei Tong, et al.
The International Journal of Biochemistry & Cell Biology|December 3, 2014
Ubiquitination of the transcription factor c-MAF is mediated by multiple lysine residuesGuodong Chen, Xin Xu, Jiefei Tong, et al.
Journal of Proteome Research|September 7, 2010
Primary tumor xenografts of human lung adeno and squamous cell carcinoma express distinct proteomic signaturesYuhong Wei, Jiefei Tong, Paul Taylor, et al.
Proteomics|February 9, 2017
Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome, and tyrosine-phosphatome in acute myeloid leukemiaJiefei Tong, Mohamed Helmy, Florence M G Cavalli, et al.
Cell|September 3, 2011
Global proteomic assessment of the classical protein-tyrosine phosphatome and "Redoxome"Robert Karisch, Minerva Fernandez, Paul Taylor, et al.
Molecular Cancer Research : MCR|March 19, 2015
CHCHD2 Is Coamplified with EGFR in NSCLC and Regulates Mitochondrial Function and Cell MigrationYuhong Wei, Ravi N Vellanki, Étienne Coyaud, et al.
Clinical Proteomics|May 5, 2012
Selected Reaction Monitoring (SRM) Analysis of Epidermal Growth Factor Receptor (EGFR) in Formalin Fixed Tumor TissueTodd Hembrough, Sheeno Thyparambil, Wei-Li Liao, et al.
British Journal of Cancer|October 11, 2025
Modeling response to the KRAS-G12C inhibitor AZD4625 in KRAS<sup>G12C</sup> NSCLC patient-derived xenografts reveals insights into primary resistance mechanismsJoshua C Rosen, Pinjiang Cao, Nhu-An Pham, et al.
ACS Chemical Biology|May 25, 2022
Engineered SH2 Domains for Targeted PhosphoproteomicsGregory D Martyn, Gianluca Veggiani, Ulrike Kusebauch, et al.
Cancers|July 24, 2019
Somatic Alteration Burden Involving Non-Cancer Genes Predicts Prognosis in Early-Stage Non-Small Cell Lung CancerDennis Wang, Nhu-An Pham, Timothy M Freeman, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Proceedings of the National Academy of Sciences of the United States of America|November 11, 2009
Multiple myeloma phosphotyrosine proteomic profile associated with FGFR3 expression, ligand activation, and drug inhibitionJonathan R St-Germain, Paul Taylor, Jiefei Tong, et al.
The International Journal of Biochemistry & Cell Biology|December 3, 2014
Ubiquitination of the transcription factor c-MAF is mediated by multiple lysine residuesGuodong Chen, Xin Xu, Jiefei Tong, et al.
Journal of Proteome Research|September 7, 2010
Primary tumor xenografts of human lung adeno and squamous cell carcinoma express distinct proteomic signaturesYuhong Wei, Jiefei Tong, Paul Taylor, et al.
Proteomics|February 9, 2017
Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome, and tyrosine-phosphatome in acute myeloid leukemiaJiefei Tong, Mohamed Helmy, Florence M G Cavalli, et al.
Cell|September 3, 2011
Global proteomic assessment of the classical protein-tyrosine phosphatome and "Redoxome"Robert Karisch, Minerva Fernandez, Paul Taylor, et al.
Molecular Cancer Research : MCR|March 19, 2015
CHCHD2 Is Coamplified with EGFR in NSCLC and Regulates Mitochondrial Function and Cell MigrationYuhong Wei, Ravi N Vellanki, Étienne Coyaud, et al.
Clinical Proteomics|May 5, 2012
Selected Reaction Monitoring (SRM) Analysis of Epidermal Growth Factor Receptor (EGFR) in Formalin Fixed Tumor TissueTodd Hembrough, Sheeno Thyparambil, Wei-Li Liao, et al.
British Journal of Cancer|October 11, 2025
Modeling response to the KRAS-G12C inhibitor AZD4625 in KRAS<sup>G12C</sup> NSCLC patient-derived xenografts reveals insights into primary resistance mechanismsJoshua C Rosen, Pinjiang Cao, Nhu-An Pham, et al.
ACS Chemical Biology|May 25, 2022
Engineered SH2 Domains for Targeted PhosphoproteomicsGregory D Martyn, Gianluca Veggiani, Ulrike Kusebauch, et al.
Cancers|July 24, 2019
Somatic Alteration Burden Involving Non-Cancer Genes Predicts Prognosis in Early-Stage Non-Small Cell Lung CancerDennis Wang, Nhu-An Pham, Timothy M Freeman, et al.
Pageof 9